Foghorn Therapeutics, Inc. (FHTX)
5.225
-0.04
(-0.67%)
USD |
NASDAQ |
Jan 08, 16:00
5.23
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics EPS Diluted (Quarterly): -0.2514 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Erasca, Inc. | -0.1079 |
| OmniAb, Inc. | -0.144 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.85M |
| Revenue (Quarterly) | 8.153M |
| Total Expenses (Quarterly) | 24.00M |
| Enterprise Value | 138.46M |
| Gross Profit Margin (Quarterly) | 88.96% |
| Profit Margin (Quarterly) | -194.4% |
| Earnings Yield | -22.71% |
| Normalized Earnings Yield | -22.71 |